Article

Contact induced dry eye

Understanding the problems of contact lens induced dry eye

Within the general population, moderate dryeye problems can be triggered by many factors including: nutrition, ageing, medications and environmental conditions. While as low as 10% of noncontact lens wearers under the age of 60 are reported to suffer from dry eye; dryness is one of the most common problems reported by contact lens wearers and in extreme cases can lead to contact lens drop out.1

To better understand the problems of contact lens induced dry eye (CLIDE) in Sweden, we sent out a survey to 25 leading Swedish contact lens fitters with the following questions:2

Q: What percentage of your contact lens wearing patients suffer from dry eye symptoms?

Q: What is your favourite prescription for solving dry-eye symptoms?

Q: If you ask your CLIDE patients to use artificial tears, do you prefer preserved or nonpreserved products?

The results from the Swedish survey were calculated and compared to results from a similar study completed in Germany.3

Ninety-two percent (n=23) of the contact lens specialists felt that high water (>50% water) soft contact lenses were the main contributor to CLIDE. In the similar German study over 40% of respondents felt the same.

Regarding which type of artificial tear is preferred, 96% (n=24) preferred to prescribe a nonpreserved product. The German study showed very similar results.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.